Skip to main
VTR
VTR logo

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas's diversified healthcare portfolio consists of nearly 1,400 properties, spanning senior housing, medical office, hospitals, life sciences, and skilled nursing/post-acute care, with a notable international presence in Canada and the United Kingdom. The company's geographic diversification and ongoing search for investment opportunities in developed healthcare markets enhance its growth potential, while management actively addresses exposure in key states to mitigate risks associated with reimbursement rate changes. With a strategic focus on maintaining occupancy and competitive positioning in a favorable interest rate environment, Ventas is well-positioned to capitalize on market opportunities, suggesting a robust outlook for its stock.

Bears say

Ventas's stock faces a negative outlook primarily due to expected reductions in Medicare and Medicaid reimbursements, which could adversely affect rent coverage ratios and lead to rent restructuring or reductions. Furthermore, the company is subject to tenant concentration risk, as significant portions of its revenue are dependent on tenants that exceed 5% of total revenue, compounding the financial impact of reimbursement cuts. Additionally, in the context of rising interest rates, the bond-like cash flows typical of healthcare REITs signal potential underperformance, while access to capital markets remains vital for the firm’s growth strategy.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.